Skip to main content Skip to secondary navigation
Main content start

RNA Targeting and Editing with CRISPR-Cas13: Dr. David Cox, Stanford University

Event Details:

Wednesday, February 24, 2021
10:00am - 11:00am PST

This event is open to:

Faculty/Staff

The ability to modify nucleic acids is critical for establishing the role of genetic elements in mediating biological phenotypes.  Manipulating endogenous DNA sequences in eukaryotic genomes has been greatly aided by the advent of genome editing technologies that utilize programmable nucleases.  RNA-guided DNA nucleases derived from class 2 CRISPR systems, which provide adaptive immunity in prokaryotes, have been particularly useful in this regard because they enable targeting of new sites through simple Watson-Crick base pairing rules.  Following the initial demonstration of DNA editing with CRISPR-Cas9, computational studies predicted the existence of RNA-targeting class 2 CRISPR systems, raising the possibility that the flexibility of CRISPR-based genome editing might be extended to the level of transcripts.

In this talk, I will present my work describing the discovery and characterization of the RNA-targeting class 2 CRISPR system: type VI-B.  Using a combination of biochemistry and bacterial genetics, we demonstrate that the predicted nuclease of the VI-B system, Cas13b, is an RNA-guided RNase, whose activity can be modulated by the csx genes that often appear in genetic proximity to cas13b.  

Additionally, we characterized the behavior of Cas13b and the related enzymes Cas13a and Cas13c in mammalian cells, identifying orthologs of Cas13a and Cas13b with specific RNA interference activity.  We also show that catalytically inactive versions of a Cas13b ortholog can direct adenosine to inosine deaminase activity to transcripts in human cells when fused to the catalytic domain of ADAR2.  Using structure-guided mutagenesis, we created a high specificity version of this system that can be utilized in research or potentially therapeutic contexts.  The description of a Cas13b ortholog that can be used to knockdown or recruit RNA modifying domains to transcripts in mammalian cells suggests the utility of this protein to interrogate and modify transcript function in diverse contexts.

 

For questions related to David Cox or his talk, please reach out to Stanley Qi at slqi@stanford.edu or to me regarding scheduling a one-on-one meeting with David Cox at eagill@stanford.edu . Thanks!

Related Topics

Explore More Events

Research seminars

Kick-starting Cardiac Regeneration

Professor Robb MacLellan, University of Washington

Tuesday, October 26, 2021 | 1:00pm - 2:00pm PDT

Research seminars

Cancer's dynamic circular genome: The role of extrachromosomal DNA (ecDNA) in cancer

Professor Paul Mischel, Stanford University

Wednesday, October 27, 2021 | 3:00pm - 4:00pm PDT

Research seminars

How do neurons and glia deal with stress and disease? New insights from CRISPR-based functional genomics

Professor Martin Kampmann, UCSF

Wednesday, October 27, 2021 | 4:00pm - 5:00pm PDT